Jo and Kim: Implications of HPV infection in uterine cervical cancer Lechner MS, and Laimins LA (1994) Inhibition of p53 DNA binding by human papillomavirus E6 proteins. J Virol 68, 4262-73. Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP, and Munger K (2000) The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci U S A 97, 10002-7. Levine AJ, Momand J, and Finlay CA (1991) The p53 tumour suppressor gene. Nature 351, 453-6. Longworth MS, and Laimins LA (2004) The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. J Virol 78, 3533-41. Maciag PC, Schlecht NF, Souza PS, Franco EL, Villa LL, and Petzl-Erler ML (2000) Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol Biomarkers Prev 9, 1183-91. Madeleine MM, Brumback B, Cushing-Haugen KL, Schwartz SM, Daling JR, Smith AG, Nelson JL, Porter P, Shera KA, McDougall JK, and Galloway DA (2002) Human leukocyte antigen class II and cervical cancer risk: a population-based study. J Infect Dis 186, 1565-74. Mandelblatt JS KP, Eggert L, and Gold K (1999) Is HIV infection a cofactor for cervical squamous cell neoplasia? Cancer Epidemiol Biomarkers Prev 8, 97-106. Melkert PW, Hopman E, van den Brule AJ, Risse EK, van Diest PJ, Bleker OP, Helmerhorst T, Schipper ME, Meijer CJ, and Walboomers JM (1991) Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. J Natl Cancer Inst 53, 919-23. Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VV, and Benezra R (2001) MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409, 355-359. Momand J, Zambetti GP, Olson DC, George D, and Levine AJ. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-45. Moodley M, Moodley J, Chetty R, and Herrington CS. (2003) The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review. Int J Gynecol Cancer 13, 103-10. Moreno V, Bosch FX, Munoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, and Franceschi S; International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group (2002) Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 359, 1085-92. Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, and Wilson CM (2000) Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med 154, 127-34. Muller CY, O'Boyle JD, Fong KM, Wistuba II, Biesterveld E, Ahmadian M, Miller DS, Gazdar AF, and Minna JD (1998) Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: association with human papillomavirus type. J Natl Cancer Inst 90, 433-9. Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M, and Zacny VL (2001) Biological activities and
molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20, 7888-98. Munger K, Phelps WC, Bubb V, Howley PM, and Schlegel R (1989) The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63, 4417-21. Munoz N, Bosch FX, Castellsague X, Diaz M, de Sanjose S, Hammouda D, Shah KV, and Meijer CJ (2004) Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111, 278-85. Murphy N, Ring M, Killalea AG, Uhlmann V, O’Donovan M, Mulcahy F, Turner M, McGuinness E, Griffin M, Martin C, Sheils O, and O'Leary JJ (2003) p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 56, 56–63. Nakashima R, Fujita M, Enomoto T, Haba T, Yoshino K, Wada H, Kurachi H, Sasaki M, Wakasa K, Inoue M, Buzard G, and Murata Y (1999) Alteration of p16 and p15 genes in human uterine tumours. Br J Cancer 80, 458-67. Odunsi KO, and Ganesan TS (1997) The roles of the human major histocompatibility complex and human papillomavirus infection in cervical intraepithelial neoplasia and cervical cancer. Clin Oncol (R Coll Radiol) 9, 4-13. Oh ST, Kyo S, and Laimins LA (2001) Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through cmyc and GC rich Sp1m binding sites. J Virol 75, 5559-66. Ojeda JM, Ampuero S, Rojas P, Prado R, Allende JE, Barton SA, Chakraborty R, and Rothhammer F (2003) p53 codon 72 polymorphism and risk of cervical cancer. Biol Res 36, 27983. Pan H, and Griep AE (1995) Temporally distinct patterns of p53dependent and p53-independent apoptosis during mouse lens development. Genes Dev 9, 2157-69. Park TW, Riethdorf S, Schulz G, Riethdorf L, Wright T, and Loning T (2003) Clonal expansion and HPV-induced immortalization are early molecular alterations in cervical carcinogenesis. Anticancer Res 23, 155-60. Pheps WC, and Howley PM (1987) Transcriptional transactivation by the human papillomavirus type 16 E2 gene product. J Virol 61, 1630–1638. Phelps WC, Yee CL, Munger K, and Howley PM (1988) The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53, 539-47. Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L, and Doxsey SJ (1998) Centrosome defects and genetic instability in malignant tumors. Cancer Res 58, 3974-3985. Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, de Sanjose S, and Munoz N; IARC Multi-centre Cervical Cancer Study Group (2003) Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control 14, 805-14. Pochylski T, and Kwasniewska A (2003) Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPVassociated high grade dysplasia and squamous cell cervical carcinoma. Eur J Obstet Gynecol Reprod Biol 111, 68-73. Poppe WA, Ide PS, Drijkoningen MP, Lauweryns JM, and van Assche FA (1995) Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study. Gynecol Obstet Invest 39, 348. Rihet S, Lorenzato M, and Clavel C (1996) Oncogenic human papillomaviruses and ploidy in cervical lesions. J Clin Pathol 49, 892-6.
432